This approach would be similar to those that had pivotal roles in localising BRCA1 through using breast–ovary cancer families (Easton et al, 1993), and cloning BRCA2 through studying breast cancer families with male breast cancer (Wooster et al, 1995). The gene discussed is BRCA2; the disease is male breast carcinoma.